12 December 2011

Editorial: HOOPS: HF death and hospitalization not affected by pharmacist consultation
By: John McMurray and Paul Armstrong
During the AHA 2011, John McMurray and Paul Armstrong discussed the HOOPS trial – a pharmacist-led primary care intervention, with the aim to reduce hospitalization and death in patients with heart failure. Did this intervention have the outcome that they hoped for? And how can the pharmacist be engaged in patient care?

12 December 2011

Editorial: TRA•CER: Vorapaxar fails to meet primary endpoint, increases bleeding risk
By: Freek Verheugt
Freek Verheugt spoke to InCirculation.net about the TRACER trial. We find out why the sweet spot was not found and ask, have we reached the ceiling of safety of dual antiplatelet therapy?

12 December 2011

Editorial: FAST: Surgical ablation ‘superior’ to catheter ablation in atrial fibrillation
By: Michael Ezekowitz and John Camm
Michael Ezekowitz and John Camm discuss the FAST trial. Is Surgical ablation ‘superior’ to catheter ablation in atrial fibrillation?